Nairobi, Kenya, 30 January 2013: The Abraaj Group, a leading private equity investor operating in global growth markets, today announced an investment by its Africa Health Fund in Vine Pharmaceuticals, the largest pharmacy retail chain in Uganda.
The investment is the Africa Health Fund’s first in the pharmaceutical retail and distribution sector. It will help Vine to expand its reach and market share in Uganda’s rapidly growing pharmaceutical market, where expenditure is growing at a CAGR of 13% and forecast to increase from the US$ 268 million spent in 2011 to US$ 545 million by 2014.
The Africa Health Fund was established in June 2009 with the International Finance Corporation, The African Development Bank, DEG, and the Bill & Melinda Gates Foundation as cornerstone investors. The Fund’s unique objective is to improve the access of low-income Africans to affordable, high quality health services while providing investors with strong long-term financial returns. The Africa Health Fund’s strategy is to tackle the issues of fragmentation in private healthcare provision and to drive economies of scale in supporting sectors such as pharmaceuticals, medical devices and diagnostic services.
Vine Pharmaceuticals was founded in 1999 and has grown to be the largest Ugandan pharmacy retailer, with 21 stores, 98 employees and a pharmaceutical import business. Abraaj will support Vine in extending its branch network outside Kampala, and building the capacity of its wholesale distribution business serving clinics, hospitals and other pharmacies.
Shakir Merali, Partner, The Abraaj Group, commented: “Vine will be an important beneficiary of the continued growth in pharmaceutical expenditure in Uganda through both its retail and wholesale businesses.”
“There will also be significant benefits for low-income Ugandans, with more consumers being put within easy reach of the basic health advice that a pharmacy can provide, and improvements to the availability of a comprehensive, up-to-date and affordable supply of drugs and other health products across the country.”
Grace Munyirwa, Founder and Director of Vine Pharmaceuticals, said: “I am proud of the work our team has done to take Vine to its leading position in the Ugandan market, and I am looking forward to taking the business to the next level with Abraaj’s support. Their expertise in the health sector and their track record of helping to grow businesses by investing in operational improvements and more sophisticated business management systems will make them the perfect partners as we expand our presence across the country and develop our promising wholesale business.”
The Abraaj Group is one of the leading private equity investors in the healthcare sector in growth markets around the world. Its Funds’ investments include stakes in the Philippines retail pharmacy chain HBC, and in Saudi Arabia’s Tadawi Group, both leaders in their local markets. Additionally, the Group has current investments in nine hospitals (following two recent successful healthcare exits in Asia), as well as in pharmaceuticals, diagnostics, and medical devices manufacturing.
In growth markets, seeing eye-to-eye on defining “impact” matters a lot less than the simple truth that responsible investing boils down to common sense. For limited partners and general partners alike, applying the policies and procedures that companies and investors in their home markets take for granted not only protects against reputational and financial risk, but also creates value. And, in the absence of codified governance, labor and environmental standards in many of these markets, private equity becomes an important driver of positive change in businesses that are as a result both profitable and sustainable. Success with a social purpose. more >
The Abraaj Group, a leading investor operating in global growth markets, today announced the acquisition, through one of its Funds, of a majority stake in Mouka Limited, a leading mattress manufacturer in Nigeria. In partnership with the Moukarim Family, Abraaj acquired its stake from previous shareholders, Actis and the founding family, with the latter retaining a minority stake in the Company. more >
The Abraaj Group today announced the completion of the full exit of its investment, through one of its Funds, in UAP Holdings Limited, a pan-African insurance holding company with subsidiaries in Kenya, Uganda, Tanzania, Rwanda and South Sudan, as well as an insurance brokerage arm in the Democratic Republic of Congo. UAP’s services include life insurance, general insurance, health insurance, premium financing services and investment management services. more >
Arif Naqvi, Group Chief Executive at The Abraaj Group and Founder of the Aman Foundation, was recognized by BNP Paribas for his outstanding contribution to philanthropy. The BNP Paribas Grand Prix for Individual Philanthropy honors an individual or family for their overall philanthropic activity, commending the exemplary nature of their actions, the social impact of their initiatives, and their long-term commitment to achieving sustainable change. more >
The Abraaj Group, a leading investor operating in global growth markets, today announced the launch of the Open Call for artists and curators to apply for the eighth edition of the prestigious Abraaj Group Art Prize. In addition, the Group announced the appointment of curator Dana Farouki as the new Chair of the Abraaj Group Art Prize. more >